The results are reported in the Sept. 17 print edition of Biochemistry, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.
"Alzheimer's disease is conventionally considered a disease of the brain gray matter because its most prominent consequence is severe memory loss," says Alex Roher, M.D., Ph.D., director of the Sun Health Research Institute in Sun City, Ariz., and lead author of the paper. The overwhelming majority of Alzheimer's research has focused on gray matter, despite the fact that white matter makes up about 50 percent of total brain tissue and is substantially altered during Alzheimer's progression, Roher says.
The prevailing theory has been that changes in the white matter are simply effects of the initial gray matter alterations, but Roher's research suggests the opposite may be the case: white matter changes could come first.
In the brain, a layer of gray tissue surrounds a whitish core, like the peel of an orange around its juicy interior. The gray exterior consists of neurons and their associated neurites -- short protrusions that communicate with neighboring neurons. This gray matter essentially acts as the brain's central processor.
Neurons send messages through the brain and to the central nervous system by transmitting electrical signals over long appendages called axons. Axons are covered with an insulating fatty sheath, known as myelin, which speeds up the transmission of the signals. Myelin is the major component of white matter.
"Ours is the first study to present a detailed biochemical analysis of white matter tissue of Alzheimer's disease patients," Roher says. The researchers studied brain tissue from two groups of people: those with autopsy-diagnosed Alzheimer's disease, and those who died from other causes with no associated dementia.
The study revealed that the total amounts of protein, lipids and cholesterol were significantly reduced in the myelin of Alzheimer's patients in comparison to the control group. This erosion of the myelin sheath is referred to as demyelination. "These profound white matter alterations undoubtedly contribute to the origin and development of Alzheimer's disease, and might possibly be the initiating step," Roher says. There are multiple reasons for arriving at this conclusion, according to Roher, but two in particular stand out.
First, previous studies have demonstrated that patients with pre-clinical Alzheimer's disease show deterioration in the white matter before the gray matter. Second, the current study suggests that white matter degeneration might be caused by a disease of the oligodendrocytes, whose main job is to produce the myelin sheath. A defective myelin coating could leave the axons unprotected, resulting in serious disturbances in nerve conduction and damage to brain functions, Roher says.
Because neurons in the gray matter are vital to cognitive activity, scientists have generally assumed that Alzheimer's disease -- with its memory loss and other cognitive debilitations -- must begin in the gray matter. But Roher says the white matter is just as critical to cognitive function. White matter axons play a major role in controlling mental activities like emotion, and all mental functions are fully expressed only when the axons are transmitting properly.
An analogy can be drawn from the recent energy crisis in California, Roher says. One of the many issues facing Californians was a short supply of power -- attributable, in part, to an unusually cold winter and a dry summer at hydroelectric dams. A suggested solution was to increase the output of coal-fired plants. But the state's infrastructure -- power lines, transfer stations, etc. -- would be unable to carry the extra power, thus negating any potential benefits. So it is with the brain's transmission infrastructure: the white matter.
The researchers found two other interesting relationships. Women tended to have more alterations in their white matter than men, a finding consistent with the general predominance of Alzheimer's cases in women. An increased level of apolipoprotein E, which has been associated with higher risk of Alzheimer's, also showed a correlation with greater demyelination.
Roher says he hopes that Alzheimer's researchers will expand their area of interest to include white matter: "Only if the full extent of Alzheimer's disease pathology is known will present attempts to intervene in the progression of the disease have any reasonable chance of success."
This study was partially supported by the State of Arizona Alzheimer's Disease Research Center and by the National Institutes of Health.
-- Jason Gorss
The online version of the research paper cited above was initially published Aug. 22 on the journal's Web site. Journalists can arrange access to this site by sending e-mail to email@example.com or calling the contact person for this release.
Alex Roher, M.D., Ph.D., is director of the Sun Health Research Institute in Sun City, Arizona.